Shin Nippon Biomedical Laboratories, Ltd.
2395.T
Price:
$1860
Market Cap:
$77.44B
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, provides drug discovery and development services in Japan and internationally. It offers pre-clinical laboratory services, such as good laboratory practice inspections; general and specific toxicity studies; pathological examinations; PK/PD of biopharmaceuticals, immunotoxicity tests, and antibody production; reproductive and developmental toxicity studies; pharmacology and pharmacological efficacy studies; and imaging services. The company also engages in the establishment and validation of analytical methods, analysis of biological samples, and calculation of pharmacokinetic parameters; and provides absorption, di...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2004-03-08
Stock Exchange
JPX
Ticker
2395.T
PE Ratio
[16.63]
ROE
[11.75%]
Current Ratio
[1.10]
Dividend Yield
[2.69%]
Enterprise Value
[104.16B]
Dividend History
The PE Ratio as of December 2025 (TTM) for Shin Nippon Biomedical Laboratories, Ltd. (2395.T) is 16.63
According to Shin Nippon Biomedical Laboratories, Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 16.63. This represents a change of -31.32% compared to the average of 24.21 of the last 4 quarters.
Shin Nippon Biomedical Laboratories, Ltd. (2395.T) Historical PE Ratio (quarterly & annually)
How has 2395.T PE Ratio performed in the past?
The mean historical PE Ratio of Shin Nippon Biomedical Laboratories, Ltd. over the last ten years is 6.17. The current 16.63 PE Ratio has changed 26.84% with respect to the historical average. Over the past ten years (40 quarters), 2395.T's PE Ratio was at its highest in in the June 2024 quarter at 118.82. The PE Ratio was at its lowest in in the December 2022 quarter at -345.56.
Average
6.17
Median
9.26
Minimum
-26.28
Maximum
19.72
Shin Nippon Biomedical Laboratories, Ltd. (2395.T) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Shin Nippon Biomedical Laboratories, Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 90.71%
Maximum Annual PE Ratio = 19.72
Minimum Annual Increase = -511.37%
Minimum Annual PE Ratio = -26.28
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 12.10 | 6.94% |
| 2024 | 11.31 | -40.12% |
| 2023 | 18.89 | 90.71% |
| 2022 | 9.91 | 24.65% |
| 2021 | 7.95 | -7.80% |
| 2020 | 8.62 | -56.30% |
| 2019 | 19.72 | -386.51% |
| 2018 | -6.88 | -73.80% |
| 2017 | -26.28 | -511.37% |
| 2016 | 6.39 | -127.31% |
Shin Nippon Biomedical Laboratories, Ltd. (2395.T) Average PE Ratio
How has 2395.T PE Ratio performed in the past?
The current PE Ratio of Shin Nippon Biomedical Laboratories, Ltd. (2395.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
14.10
5-year avg
12.03
10-year avg
6.17
Shin Nippon Biomedical Laboratories, Ltd. (2395.T) PE Ratio vs. Peers
How is 2395.T’s PE Ratio compared to its peers?
Shin Nippon Biomedical Laboratories, Ltd.’s PE Ratio is greater than ASKA Pharmaceutical Holdings Co.,Ltd. (11.46), greater than Vital KSK Holdings, Inc. (6.65), greater than TAUNS Laboratories, Inc. (13.47), less than Kitazato Corporation (0), greater than Cawachi Limited (13.86), greater than Shofu Inc. (16.09), less than EM Systems Co., Ltd. (30.56), greater than Japan Eyewear Holdings Co., Ltd. (11.32), greater than Amvis Holdings, Inc. (11.81), greater than Qol Holdings Co., Ltd. (11.37),
| Company | PE Ratio | Market cap |
|---|---|---|
| 11.46 | $58.12B | |
| 6.65 | $65.59B | |
| 13.47 | $53.57B | |
| 0 | $62.48B | |
| 13.86 | $65.84B | |
| 16.09 | $65.17B | |
| 30.56 | $56.56B | |
| 11.32 | $47.80B | |
| 11.81 | $43.22B | |
| 11.37 | $85.28B |
Build a custom stock screener for Shin Nippon Biomedical Laboratories, Ltd. (2395.T) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shin Nippon Biomedical Laboratories, Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Shin Nippon Biomedical Laboratories, Ltd. (2395.T) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Shin Nippon Biomedical Laboratories, Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Shin Nippon Biomedical Laboratories, Ltd.'s PE Ratio?
How is the PE Ratio calculated for Shin Nippon Biomedical Laboratories, Ltd. (2395.T)?
What is the highest PE Ratio for Shin Nippon Biomedical Laboratories, Ltd. (2395.T)?
What is the 3-year average PE Ratio for Shin Nippon Biomedical Laboratories, Ltd. (2395.T)?
What is the 5-year average PE Ratio for Shin Nippon Biomedical Laboratories, Ltd. (2395.T)?
How does the current PE Ratio for Shin Nippon Biomedical Laboratories, Ltd. (2395.T) compare to its historical average?